Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
1.595
-0.155 (-8.86%)
At close: Nov 20, 2026, 4:00 PM EST
1.630
+0.035 (2.19%)
After-hours: Nov 20, 2026, 7:57 PM EST
Atossa Therapeutics Employees
Atossa Therapeutics had 16 employees as of December 31, 2025. The number of employees increased by 1 or 6.67% compared to the previous year. That makes Atossa Therapeutics the 38,972nd largest employer in the world and 5,644th in the United States.
Employees
16
Change (1Y)
1
Growth (1Y)
6.67%
Revenue / Employee
n/a
Profits / Employee
-$2,165,938
Market Cap
15.92M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 16 | 1 | 6.67% | 16 | 0 |
| Dec 31, 2024 | 15 | 3 | 25.00% | 15 | 0 |
| Dec 31, 2023 | 12 | 1 | 9.09% | 12 | 0 |
| Dec 31, 2022 | 11 | 3 | 37.50% | 11 | 0 |
| Dec 31, 2021 | 8 | 0 | - | 6 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Evaxion | 46 |
| BeyondSpring | 44 |
| Context Therapeutics | 15 |
| CervoMed | 15 |
| Lipocine | 14 |
| NewcelX | 12 |
| Cocrystal Pharma | 10 |
ATOS News
- 10 days ago - Atossa Therapeutics reports Q3 EPS (56c) vs. ($1.01) - TheFly
- 10 days ago - Atossa Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update - PRNewsWire
- 10 days ago - Atossa Therapeutics Quarterly report: Q3 2026 - Filings
- 10 days ago - Atossa Therapeutics Earnings release: Q3 2026 - Filings
- 4 weeks ago - Atossa Therapeutics says common stock to begin trading with stapled CVR - TheFly
- 4 weeks ago - Atossa Therapeutics Common Stock to Begin Trading with Stapled Contingent Value Rights After Close of Business Today - PRNewsWire
- 6 weeks ago - Atossa Therapeutics enters Stapled Contingent Value Rights Agreement - TheFly
- 6 weeks ago - Atossa Therapeutics Executes Contingent Value Rights Agreement Providing Shareholders Participation in Potential Priority Review Voucher Value - PRNewsWire